Model-informed Infliximab Dose De-escalation Following Earlier Dose Escalation in Adult Patients With Inflammatory Bowel Diseases
Latest Information Update: 11 Jul 2024
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- Acronyms MODIFI
- 05 Jul 2024 Status changed from recruiting to completed.
- 11 Feb 2022 Status changed from not yet recruiting to recruiting.
- 06 Aug 2021 New trial record